LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 29.86 | 21.74 | 909 | 1887 | 0.4817 | 0.7856 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 31.83 | 21.74 | 835 | 2110 | 0.3957 | 0.7380 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 31.83 | 21.74 | 998 | 2110 | 0.4730 | 0.7855 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 31.83 | 21.74 | 1 | 2110 | 0.0005 | -0.3728 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 31.83 | 21.74 | 952 | 2110 | 0.4512 | 0.7728 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 33.80 | 21.74 | 860 | 2381 | 0.3611 | 0.7209 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 33.80 | 21.74 | 1029 | 2381 | 0.4321 | 0.7670 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 33.80 | 21.74 | 1 | 2381 | 0.0004 | -0.3652 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 33.80 | 21.74 | 997 | 2381 | 0.4186 | 0.7588 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 35.77 | 21.74 | 916 | 2602 | 0.3519 | 0.7192 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 35.77 | 21.74 | 1071 | 2602 | 0.4115 | 0.7586 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 35.77 | 21.74 | 4 | 2602 | 0.0015 | -0.2175 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 35.77 | 21.74 | 1031 | 2602 | 0.3961 | 0.7489 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 37.74 | 21.74 | 967 | 2828 | 0.3419 | 0.7166 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 37.74 | 21.74 | 1118 | 2828 | 0.3953 | 0.7524 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 37.74 | 21.74 | 8 | 2828 | 0.0028 | -0.1327 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 37.74 | 21.74 | 1085 | 2828 | 0.3836 | 0.7450 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 39.71 | 21.74 | 994 | 3084 | 0.3223 | 0.7070 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 39.71 | 21.74 | 1131 | 3084 | 0.3667 | 0.7381 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 39.71 | 21.74 | 8 | 3084 | 0.0026 | -0.1305 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 39.71 | 21.74 | 1113 | 3084 | 0.3609 | 0.7342 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 41.68 | 21.74 | 1047 | 3418 | 0.3063 | 0.7006 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 41.68 | 21.74 | 1167 | 3418 | 0.3414 | 0.7261 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 41.68 | 21.74 | 7 | 3418 | 0.0020 | -0.1438 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 41.68 | 21.74 | 1169 | 3418 | 0.3419 | 0.7265 | MN20160310_N01 | N12 |